Acanthosis nigricans in obese women in a mixed-race population: A marker of metabolic disturbances;Acanthosis nigricans em mulheres obesas de uma população miscigenada: Um marcador de distúrbios metabólicos

Anais Brasileiros de Dermatologia

Volumn 77, Issue 5, 2002, Pages 537-543

  Batista Araújo, Leila Maria ^a,c   Vaz Porto, Marcus ^a   Ursich, Mileni J M ^b   Costa de Viveiros, Adriano Moura ^a   De Carvalho Viana, Aldenice ^a   Cruz Lopes, Renata ^a   Fukui, Rosa T ^b  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c University Hospital   (Brazil)

Author keywords

Acanthosis nigricans; Diabetes mellitus non insulin dependent; Insulin resistance; Metabolism; Obesity; Racial stocks

Indexed keywords

CHOLESTEROL; INSULIN; TRIACYLGLYCEROL;

ACANTHOSIS NIGRICANS; ADOLESCENT; ADULT; AGED; ANTHROPOMETRIC PARAMETERS; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORAL GLUCOSE TOLERANCE TEST; OUTPATIENT DEPARTMENT; RACE DIFFERENCE; SCREENING; SKIN COLOR; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0036761268     PISSN: 03650596     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0365-05962002000500003     Document Type: Article

References (24)

1. Schwartz RA. Acanthosis nigricans. J Am Acad Dermatol 1994; 31:1-19.
2. Kahn CR, Flier JS, Bar RS, et al. The syndromes of insulin resistance and acanthosis nigricans: Insulin-receptor disorders in man. N Engl J Med 1976; 294:739-45.
3. Flier JS. Metabolic importance of acanthosis nigricans. Arch Dermatol 1985; 121:193-4.
4. Peters EJ, Stuart CA, Prince MJ. Prevalence of acanthosis nigricans and obesity: Acquired and intrinsic defects in insulin action. Metabolism Clin Exp 1986; 35:807-13.
5. Dunaif A, Graf M, Mandeli J, Laumas V, Dobrjanski A. Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia. J Clin Endocrinol Metab 1987; 65:499.
6. Matsuoka LY, Wortsman J, Gavin JR, Goldman J. Spectrum of endocrine abnormalities associated with acanthosis nigricans. Am J Med 1987; 83:719-25.
7. Flier JS, Eastman RC, Minaker KL, Matteson D, Rowe JW. Acanthosis nigricans in obese women with hyperinsulinemia. J Clin Endocrinol Metab 1987; 65:499.
8. Barth JH, Ng LL, Wojnarowska F. Acanthosis nigricans, insulin resistance and cutaneous virilism. Br J Dermatol 1988; 118:613
9. Stuart CA, Pate CJ, Peters EJ. Prevalence of acanthosis nigricans in an unselected population. Am J Med 1989, 87:269-72.
10. Hud JA Jr, Cohen JB, Wagner JM, Cruz PD. Prevalence and significance of acanthosis nigricans in an adult obese population. Arch Dermatol 1992; 128:941-4.
11. Stuart CA, Smith MM, Gilkison CR, Shaheb S, Stahn RM. Acanthosis nigricans among native Americans: An indicator of high diabetes risk. Am J Publ Health 1994; 84:1839-42.
12. Panidis D, Skiadopoulos S, Rousso D, Joannides D, Panidou E. Association of acanthosis nigricans with insulin resistance in patients with polycystic ovary syndrome. Brit J Dermatol 1995; 132:936-41.
13. Esperanza LE, Fenske NA. Hyperandrogenism, insulin resistance, and acanthosis nigricans (HAIR-AN) syndrome: Spontaneous remission in a 15-year-old-girl. J Am Acad Dermatol 1996; 34:892-97.
14. Stuart CA, Gilkison CR, Keenan BS, Nagamani M. Hyperinsulinemia and acanthosis nigricans in African Americans. J Natl Med Assoc 1997; 89:523-7.
15. Burke PB, Hazuda HP, Hale DE, Stern MP. A quantitative scale of acanthosis nigricans. Diabetes Care 1999; 22:1655-59.
16. World Health Organization. Diabetes Mellitus: Report of a WHO Study Group. Geneva, World Health Organization, 1995 (Teach Rep Ser, n° 727).
17. Krieger H, Morton NE, Mi MP, Azevêdo E, Maia AF, Yasuda N. Racial admixture in north-eastern Brazil. Am Hum Genet Loud 1965; 25:113-6.
18. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RI. Homeostase model assessment: Insulin resistance and insulin concentrations in man. Diabetologia 1985; 28:412-9.
19. Sociedade Brasileira de Cardiologia. II Consenso Brasileiro sobre Dislipidemia. Arq Bras Card 1996; 67,113-8.
20. Gilkson C & Stuart CA. Assessment of patients with acanthosis nigricans skin lesion for hyperinsulinemia, insulin resistance and diabetes risk. Nurse Pract 1992; 17:26-44.
21. Moller DE, Flier JS. Insulin resistance mechanisms, syndromes, and implications. N Engl J Med 1991; 325:938-48.
22. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37:1595.
23. Kaplan NN. The deadly quarter. Upper body obesity, glucose intolerance, hipertriglyceridaemia and hypertension. Arch Intern Med 1989; 49:1514.
24. Schmidt MI, Watson RL, Duncan BB, Metcalf P, Brancati FL, Sharrett R, Davis CE, Heirs G. Clustering of dyslipidemia, hiperuricemia, diabetes and hypertension and its association with fasting insulin and central and overall obesity in a general population. Metabolism Clin Exp 1996; 45:699-706.